2 Healthcare Stocks That Could Soar Over the Next 5 Years

Core Viewpoint - The stock market is currently volatile, but there is potential for good performance over the next five years, particularly in healthcare stocks like Moderna and Abivax [1]. Group 1: Moderna - Moderna's shares have the potential to increase significantly as it advances its mRNA platform, which offers faster production and stronger immune responses compared to traditional vaccines [3]. - The company is developing a flu vaccine aimed at improving efficacy, which currently ranges from 40% to 60% for existing options [3]. - The most promising candidate is mRNA-4157, a personalized cancer vaccine that has shown significant results in reducing recurrence or death in advanced melanoma patients when combined with Keytruda [4]. - Moderna's shares have increased by approximately 73% this year, and the company is expected to maintain momentum as it progresses with other programs [5]. Group 2: Abivax - Abivax, a French biotech company, aims to disrupt the ulcerative colitis drug market, which is dominated by major pharmaceutical companies [6]. - The leading candidate, obefazimod, is promising as it avoids the immune suppression issues associated with many current treatments, which can increase the risk of certain diseases [6].